Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-275-2 | CAS number: 137-05-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: other routes
Administrative data
- Endpoint:
- chronic toxicity: other route
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented publication which meets basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 966
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Mecrilate
- EC Number:
- 205-275-2
- EC Name:
- Mecrilate
- Cas Number:
- 137-05-3
- Molecular formula:
- C5H5NO2
- IUPAC Name:
- methyl 2-cyanoprop-2-enoate
- Test material form:
- other: liquid
- Details on test material:
- Methyl-2-cyanoacrylate monomer with 20 % polymer
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- ANIMALS: 141 rats, 67 females and 74 males
Administration / exposure
- Route of administration:
- subcutaneous
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- Methyl 2-cyanoacrylate monomer (with 20 % polymer) in volumes of 0.1 mL and 0.4 mL were injected into the dorsal subcutis of Sprague Dawley rats.
The rats were anesthetized, and a wide, shallow pocket was prepared by blunt dissection of the dorsal subcutis, using aseptic techniques.
The methyl 2-cyanoacrylate was then introduced into the pocket in the specified amount with a 26 gauge needle, and spread by gentle massage.
The incisions were closed with skin clips. Each rat was given a single injection of test material or saline as control. - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 19.5 m
- Frequency of treatment:
- once
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0.1 other: mL
- Remarks:
- single subcutane injection
- Dose / conc.:
- 0.4 other: mL
- Remarks:
- single subcutane injection
- No. of animals per sex per dose:
- see "Any other information on materials and methods"
- Control animals:
- yes
Examinations
- Observations and examinations performed and frequency:
- Growth and mortality records were kept. The injected sites were observed frequently at the onset and at approximately monthly intervals thereafter.
- Sacrifice and pathology:
- Some rats in each group were killed after 6 and 12 months, and all survivors after 19.5 months.
All animals were autopsied and tissues prepared for histopathological examination. - Other examinations:
- no data
- Statistics:
- no data
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- see "Any other information on results"
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- see "Any other information on results"
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- see "Any other information on results"
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- see "Any other information on results"
- Histopathological findings: neoplastic:
- not examined
Effect levels
- Key result
- Dose descriptor:
- NOAEL
- Remarks on result:
- not determinable
- Remarks:
- no NOAEL identified
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
CLINICAL RESULTS
Single injections of 0.1 mL or 0.4 mL of methyl 2 -cyanoacrylate had no untoward effect on the growth of the rats.
A firm lump of polymer was palpable underneath the skin within one minute after implantation of the adhesive. A marked inflammatory reaction was seen at the implant site within 24 hours. The gross tissue reaction subsided within 2 weeks in some rats, and persisted in others. Firm masses were found at the implant site in all rats given 0.4 mL of adhesive; smaller masses or fine, gritty granules were found in the rats given 0.1 mL of adhesive. The areas containing the polymer gradually decreased in size; palpable masses were noted in all surviving rats implanted with 0.4 mL of the adhesive after one year, and in ten of the eleven survivors at 15 months. In the rats given 0.1 mL of the adhesive, palpable masses were found in 56 % at 3 months, 42 % at 6 months, and in 14% at 12 months; and at 19.5 months a small mass was found in only one of the survivors in this group.
AUTOPSY
At autopsy, the polymer was found as small, white, opaque, brittle particles, or irregular shaped, hard, semi-crystalline, friable fragments of varying dimensions, some lesion sites measuring as much as 1.5 x 1.0 x 0.3 cm. The material was usually found in a thick-walled capsule embedded in caseous material.
After the tissue had been sectioned for histological preparation, the recoverable residue was dried and weighed. The largest amount recovered from the 0.4 mL implants was 182 mg in a rat killed after 8 months. In the ten rats given 0.4 mL of adhesive and killed after 6 months, the weights of the recovered residue ranged from 5-81 mg, with a mean of 59 mg for nine rats; the polymer in the tenth rat extruded after 3 months. Polymer was found at the implant site in seventeen of the eighteen rats injected with 0.4 mL of adhesive and killed after 12 months. The amount recovered varied from less than 1.0 mg to 78 mg; the mcan was 45 mg; extrusion had occurred in the eighteenth rat after six months.
In the group of rats given 0.1 mL of adhesive, small amounts of polymer were recovered from four of the ten rats killed after 6 months. Polymer was found grossly in two of the fourteen rats killed after 12 months (less than 1 mg in one, and 72 mg in the second rat).
Extrusion of the polymer occurred in nine rats given 0.4 mL; five within 2 months, two within 6 months, and two within 1 year. The polymer was extruded after 2, 3, and 12 months in three rats implanted with 0.1 mL of the adhesive.
A recurrence of persistent edema and hyperemia in the area containing the polymer was seen grossly in a few rats at about 5 months after implantation of the adhesive. Large abscesses developed in a few of these rats; in others, the reaction subsided gradually.
Tumors varying in size from 1.0 x 0.9 cm to 8.0 x 8.0 x 7.0 cm occurred at the irnplant site in eight rats implanted with 0.4 mL of methyl 2 -cyanoacrylate; polymer was found grossIy in two of these tumors. The first tumor arising at the implant site was detected at 11 months post-injection.
The study was set up for 2 years. However, there were frequent epizootics of pneumonia in the animal room, which caused a mortality of about 30 %; and a severe outbreak of murine pneumonia at 19.5 months caused the termination the study.
HISTOPATHOLOGY
The tissues examined for histopathological conditions from animals sacrificed or which died during the first 19 months of the study were: lung, heart, liver, kidney, adrenal, small intestine, pancreas, testis or ovary, and subcutis. The tissue examined from animals sacrificed at the end of the study (19.5 months) were: brain, thyroid, salivary gland, heart, lung, Iiver, kidney, spleen, adrenal, pancreas, stomach,small and large intestine, testis, ovary, uterus, urocyst, lymph node, pituitary, bone marrow, subcutis, and skin.
Polymer in subcutis following 0.1 mL lnjection: Of four sites examined after 4 months, three contained polymer and one contained exudate only. At 6 months, five of seven sites examined contained polymer and two only exudate. At 12 months, two sites had polymer remaining, one site showed only exudate, another site showed a small focus of inflammatory cells, and in the remaining seven rats no site or deposit was discernable on study. At termination of study (19.5 months) no deposit or site remained in the subcutis of seven rats, and the eighth rat showed a suspicious Iesion.
In the group given 0.4 mL adhesive, in nine rats examined after 6 months, injected material was present in all. In the period of 4-18 months in which rats died or were killed, of twelve sites examined, three contained deposits of polymer alone, one had exudate only, one showed graulation tissue, one consisted of a granuloma undergoing malignant transformation, one contained polymer with early sarcomatous change, four were sarcomatous, and one had neither deposit nor site change. At termination of study (19.5 months) seven areas of injection were examined. One was without deposit or tissue reaction, four contained residual polymer, one had polymer and neoplastic transformation of tissue reaction, and one had sarcoma.
Tissue response of the host to methyl 2 -cyanoacrylate was similar generally to both 0.1 and 0.4 mL injected, and it did not change its essential features during the study except for neoplastic transformation in a number of rats which were injected with 0.4 mL. The lesion, with slight variation, consisted of a cavity, and a relatively narrow wall composed of several zones. The cavity contained either polymer which was not birefringent when examined with polarizing light, and/or an eosinophilic exudate densely infiltrated with polymorphonuclear Ieucocytes, and basophilic granules were also found in the cavity. The wall surrounding the cavity had an inner zone of macrophages at the lumen, and an outer zone of fibroblasts and fibrocytes. Occasionally, the inner zone contained fibrocytes and/or giant cells, the outer zone clusters of lymphocytes and/or pigment-laden macrophages. Large and small particles of calcic material (alizarin red positive) were found within the cavity and wall.
Neoplastic transformation of the tissues surrounding the deposits of polymer developed in rats injected with 0.4 mL. The neoplasms were fibrosarcomas which varied in histomorphic configuration from poorly differentiated to well differentiated. The capsule of the implant site underwent sarcomatous change in eight of the fifty-nine rats injected with 0.4 mL of the adhesive, and in two of these animals the fibrosarcoma metastasized to the lung.
At termination (19.5 months), the injected site in one rat which recieved 0.1 mL adhesive showed areas of metaplasia and what appeared to be focal anaplastic proliferation of cells of the fibrocytic series. The metaplastic area was osteogenetic and relatively large. The anaplastic cells arose in this area and did not penetrate the mature fibrous wall of the capsule.
Spontaneous tumors were infrequent and consisted of four mammary fibro-adenomas; one in the control group, one in 0.1 mL group, and two in 0.4 mL group; a sarcoma (hair papilla) of the leg in the control group, a fibroma of the leg in the 0.1 mL group, and a plasmacytoma of the lung, a granulosa cell tumor, and a basophil adenoma of the pituitary in the 0.4 group.
The was a high incidence of fortuitous lesions, mainly murine pneumonia, in the organs and tissues of the rats in all groups, but none was unusuaI for aging rats, and none was attributable to systemic effects of the adhesive injected.
Applicant's summary and conclusion
- Conclusions:
- This study indicates a carcinogenetic effect of methyl 2-cyanoacrylate in rats which have a large aggregate of polymer in the subcutis that persists for more than eleven months.
- Executive summary:
Single subcutaneous injections of methyl 2-cyanoacrylate were given in volumes of 0.1 mL and 0.4 mL to Sprague Dawley rats to evaluate tissue reaction and fate over a period of 19.5 months. The fluid adhesive polymerized rapidly into a palpable mass following introduction into the cutis. The rate at which polymer disappeared from the injection site varied considerably. The injected material caused no discernible systemic effects; it induced a calcifying cavitary Iesion surrounded by a wall composed of macrophages at the inner aspect and a fibrocellular capsule at the periphery.
Fibrosarcoma was found at the site of injection in eight of fifty-nine rats injected with 0.4 methyl 2-cyanoacrylate, and in two of these rats the fibrosarcoma metastasized to the lung. Onset of tissue proliferation was first observed clinically at 11 months after injection and occurred at varying periods up to termination of experiment at 19.5 months. The first of the fibrosarcomas at the injection site was found in a rat killed fourteen months after injection, and the other seven were found thereafter in animals which died or were killed up to the termination of the study at 19.5 months.
One of the fifty-six rats injected with 0.1 mL of methyl 2 -cyanoacryIate that was killed at 19.5 months (termination of study) had changes suggestive of early sarcomatous transformation but, because of an area of metaplastic osseous development in the lesion, it was not possible to determine whether the anaplasia of connective tissue developed as a result of the presence of adhesive or the presence of the osseous mass.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.